New autoantibody mediated disorders of the central nervous system

Current Opinion in Neurology

Volumn 16, Issue 3, 2003, Pages 351-357

  Lang, Bethan ^a   Dale, Russell C ^b   Vincent, Angela ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Autoantibodies; Autoimmunity; Central nervous system

Indexed keywords

AUTOANTIBODY; CALCIUM CHANNEL; CARDIOLIPIN ANTIBODY; GLUTAMATE DECARBOXYLASE; GLUTAMATE DECARBOXYLASE ANTIBODY; GLUTAMATE RECEPTOR; IMMUNOGLOBULIN; PHOSPHOLIPID ANTIBODY; POTASSIUM CHANNEL; RIBONUCLEOPROTEIN;

ANTIBODY SPECIFICITY; AUTOIMMUNITY; BLOOD BRAIN BARRIER; CELIAC DISEASE; CENTRAL NERVOUS SYSTEM DISEASE; CENTRAL NERVOUS SYSTEM FUNCTION; CEREBELLAR ATAXIA; CHANNEL GATING; CHOREA MINOR; CYTOTOXIC T LYMPHOCYTE; DISEASE COURSE; EPILEPSY; EXTRAPYRAMIDAL SYMPTOM; NONHUMAN; PARANEOPLASTIC NEUROPATHY; PATHOGENICITY; PHENOTYPE; PROTEIN BLOOD LEVEL; PROTEIN CEREBROSPINAL FLUID LEVEL; RASMUSSEN SYNDROME; REVIEW; STIFF MAN SYNDROME; STREPTOCOCCUS PYOGENES; TIC;

ANIMALS; AUTOANTIBODIES; AUTOANTIGENS; AUTOIMMUNE DISEASES; AUTOIMMUNE DISEASES OF THE NERVOUS SYSTEM; CALCIUM CHANNELS; CELIAC DISEASE; CENTRAL NERVOUS SYSTEM DISEASES; CEREBELLAR ATAXIA; ENCEPHALITIS; EPILEPSY; GLUTAMATE DECARBOXYLASE; HUMAN T-LYMPHOTROPIC VIRUS 1; HUMANS; LIMBIC ENCEPHALITIS; LUPUS ERYTHEMATOSUS, SYSTEMIC; PARANEOPLASTIC CEREBELLAR DEGENERATION; POTASSIUM CHANNELS; RECEPTORS, AMPA; RECEPTORS, GLUTAMATE; STREPTOCOCCAL INFECTIONS; SYRINGOMYELIA;

EID: 0038119837     PISSN: 13507540     EISSN: None     Source Type: Journal    
DOI: 10.1097/00019052-200306000-00016     Document Type: Review

References (37)

1. Vincent A, Beeson D, Lang B. Molecular targets for autoimmune and genetic disorders of neuromuscular transmission. Eur J Biochem 2000; 267:6717-6728.
2. Vincent A. Unravelling the pathogenesis of myasthenia gravis. Nat Rev Immunol 2002; 10:797-804.
3. Sutton I. Paraneoplastic neurological syndromes. Curr Opin Neurol 2002; 15:685-690. Comprehensive review of recent advances in aetiology and treatment of paraneoplastic neurological syndromes.
4. Graus F, Lang B, Pozo-Rosich P, et al. P/Q type calcium channel antibodies in paraneoplastic cerebellar degeneration with lung cancer. Neurology 2002; 59:764-766. Anti-VGCC antibodies are detected in sera and in CSF of patients with cerebellar degeneration and cancer, more commonly than Hu antibodies, suggesting a possible role of VGCC antibodies in causing cerebellar symptoms.
5. 1A calcium channel subunit reduce both P-type and Q-type calcium channel currents in cerebellar neurones. Proc Natl Acad Sci U S A 1998; 95:8328-8333.
6. Bushara KO, Goebel SU, Shill H, et al. Gluten sensitivity in sporadic and hereditary cerebellar ataxia. Ann Neurol 2001; 49:540-543.
7. Luostarinen LK, Collin PO, Peraaho MJ, et al. Coeliac disease in patients with cerebellar ataxia of unknown origin. Ann Med 2001; 33:445-449.
8. Hadjivassiliou M, Boscolo S, Davies-Jones GA, et al. The humoral response in the pathogenesis of gluten ataxia. Neurology 2002; 58:1221-1226.
9. Rogers SW, Andres PI, Gahring LC, et al. Autoantibodies to glutamate receptor GluR3 in Rasmussen's encephalitis. Science 1994; 265:648-651.
10. Levite M, Hart I. Immunotherapy for epilepsy. Expert Rev Neurother 2002; 2:809-814.
11. Bernasconi P, Cipelletti B, Passerini L, et al. Similar binding to glutamate receptors by Rasmussen's and partial epilepsy patients sera. Neurology 2002; 59:1998-2001.
12. Mantegazza R, Bernasconi P, Baggi F, et al. Antibodies against GluR3 peptides are not specific for Rasmussen's encephalitis but are also present in epilepsy patients with severe early onset disease and intractable seizures. J Neuroimmunol 2002; 131:179-185. Antibodies to peptides derived from the sequence of the GluR3 receptor were detected in the sera of both Rasmussen's encephalitis and patients with frequent seizures. Anti-GluR3 antibodies appear to be specific for epilepsy, but not for Rasmussen's encephalitis.
13. + cytotoxic T-cells and MHC class I neurones in the brain of Rasmussen's encephalitis patients.
14. Levite M. Autoimmune epilepsy. Nat Immunol 2002; 3:500.
15. Costa M, Saiz A, Casamitjana R, et al. T-cell reactivity to glutamic acid decarboxylase in stiff-man syndrome and cerebellar ataxia associated with polyendocrine autoimmunity. Clin Exp Immunol 2002; 129:471-478.
16. Dalakas M, Fujji M, Li M, et al. High dose intravenous immune globulin for stiff-person syndrome. N Eng J Med 2001; 26:1870-1876. Well controlled immunomodulatory therapy trial in a rare CNS disorder, which demonstrates a good clinical response, related to a fall in antibody titre.
17. Dalakas M, Li M, Fujii M, Jacobowitz D. Stiff person syndrome: quantification, specificity and intrathecal synthesis of GAD65 antibodies. Neurology 2001; 57:780-784.
18. Peltola J, Kulmala P, Isojarva J, et al. Antibodies to glutamic acid decarboxylase in patients with therapy resistant epilepsy. Neurology 2000; 55:46-50.
19. Honnorat J, Saiz A, Giometto B, et al. Cerebellar ataxia with anti-glutamic acid decarboxylase antibodies. Arch Neurol 2001; 58:225-230.
20. Mitoma H, Song S-Y, Ishida K, et al. Presynaptic impairment of cerebellar inhibitory synapses by an autoantibody to glutamate decarboxylase. J Neurol Sci 2002; 175:40-44. Anti-GAD antibodies exert a functional effect on GABA-mediated transmission in rat cerebellar cells.
21. Chattopadhyay S, Ito M, Cooper J, et al. An autoantibody inhibitory to glutamic acid decarboxylase in the neurodegenerative disorder Batten disease. Human Mol Genet 2002; 11:1421-1431. Surprising occurrence of anti-GAD antibodies in an autosomal recessive neurodegenerative disorder Batten's disease.
22. Hart IK, Maddison P, Newsom-Davis J, et al. Phenotypic variants of autoimmune peripheral nerve hyperexcitability. Brain 2002; 125:1887-1895.
23. Vernino S, Lennon VA. Ion channel and striational antibodies define a continuum of autoimmune neuromuscular hyperexcitability. Muscle Nerve 2002; 26:702-707.
24. Liguori R, Vincent A, Clover L, et al. Morvan's syndrome: peripheral and central nervous system and cardiac involvement with antibodies to voltage-gated potassium channels. Brain 2001; 124:2417-2426.
25. Buckley C, Oger J, Clover L, et al. Potassium channel antibodies in two patients with reversible limbic encephalitis. Ann Neurol 2001; 50:73-78. Anti-VGKC antibodies detected in sera of patients with a limbic encephalitis-like disorder. Reduction in antibody levels alleviated the symptoms.
26. Arimura K, Sonoda Y, Watanabe O, et al. Isaacs' syndrome as a potassium channelopathy of the nerve. Muscle Nerve Suppl 2002; 11 :S55-S58.
27. Swedo SE, Leonard HL, Garvey M, et al. Pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections: clinical description of the first 50 cases. Am J Psychiatry 1998; 155:264-271.
28. Dale RC, Church AJ, Benton S, et al. Post-streptococcal autoimmune dystonia with isolated bilateral striatal necrosis. Dev Med Child Neurol 2002; 44:485-489.
29. Dale RC, Church AJ, Surtees RAH, et al. Post-streptococcal autoimmune CNS disease presenting as paroxysmal dystonic choreoathetosis. Mov Disord 2002; 17:817-820.
30. Church AJ, Cardoso F, Dale RC, et al. Anti-basal ganglia antibodies in acute and persistent Sydenham's chorea. Neurology 2002; 59:227-231. This paper compares three different anti-neuronal antibody techniques (enzyme-linked immunosorbant assay, Western blotting and immunohistochemistry) in Sydenham's chorea compared with rheumatic fever and healthy controls. This group used human basal ganglia as the autoantigen.
31. Hallett JJ, Harling-Berg CJ, Knopf PM, et al. Anti-striatal antibodies in Tourette syndrome cause neuronal dysfunction. J Neuroimmunol 2000; 111:195-202.
32. Dale RC, Church AJ, Cardoso F, et al. Poststreptococcal acute disseminated encephalomyelitis with basal ganglia involvement and auto-reactive antibasal ganglia antibodies. Ann Neurol 2001; 50:588-595.
33. Jennekens FG, Kater L. The central nervous system in systemic lupus erythematosus: part 2. Pathogenetic mechanisms of clinical syndromes: a literature investigation. Rheumatology (Oxford) 2002; 41:619-630.
34. DeGiorgio LA, Konstantinov KN, Lee SC, et al. A subset of lupus anti-DNA antibodies cross-reacts with the NR2 glutamate receptor in systemic lupus erythematosus. Nat Med 2001; 7:1189-1193. Using predominantly immunohistochemical techniques, this group demonstrated cross-reactivity between anti-DNA antibodies and NMDA receptors resulting in neuronal death.
35. 2 glycoprotein 1 and anti-prothrombin antibodies in young patients with epilepsy. Epilepsia 2002; 43:52-59.
36. Levin MC, Lee SM, Kalume F, et al. Autoimmunity due to molecular mimicry as a cause of neurological disease. Nat Med 2002; 8:509-513. Using classic electrophoresis and proteomic techniques, this group demonstrated cross-reactivity between viral and self epitopes in HTLV-1 CNS disease.
37. Hickey WF. Basic principles of immunological surveillance of the normal central nervous system. Glia 2001; 36:118-124. This paper comprehensively reviews the recent developments and future questions in the field of immune surveillance of the brain under normal and pathological situations.